The swine flu vaccine and Guillain-Barré syndrome: A case study in relative risk and specific causation

Evaluation Review

Volumn 23, Issue 6, 1999, Pages 619-647

  Freedman, D A ^a   Stark, Philip B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; EPIDEMIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; INFLUENZA VIRUS A; LEGAL ASPECT; LEGAL LIABILITY; MALE; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; RISK; STATISTICAL MODEL; UNITED STATES;

CAUSALITY; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA A VIRUS; INFLUENZA VACCINES; LIABILITY, LEGAL; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK; UNITED STATES;

EID: 0033451345     PISSN: 0193841X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0193841X9902300603     Document Type: Article

References (36)

1. American Medical Association, Council on Scientific Affairs. 1987. Radioepidemiological tables. Journal of the American Medical Association 257:806-9.
2. Bailey, L. A., L. Gordis, and M. Green. 1994. Reference guide on epidemiology. In Reference Manual on Scientific Evidence. Washington, DC: Federal Judicial Center.
3. Beghi, E., L. T. Kurland, D. W. Mulder, and W. C. Wiederholt. 1985. Guillain-Barré syndrome: Clinicoepidemiologic features and effect of influenza vaccine. Archives of Neurology 42:1053-57.
4. Beyea, J., and S. Greenland. 1999. The importance of specifying the underlying biologic model in estimating the probability of causation. Health Physics 76:269-74.
5. Black, B., and D. E. Lilienfeld. 1984. Epidemiologic proof in toxic tort litigation. Fordham Law Review 52:732-85.
6. Freedman, D. 1973. Another note on the Borel-Cantelli lemma and the strong law with the Poisson approximation as a byproduct. Annals of Probability 1:910-25.
7. _. 1999. From association to causation: Some remarks on the history of statistics. Technical report 537. Department of Statistics, University of California, Berkeley.
8. Hahn, A. F. 1998. Guillain-Barré syndrome. Lancet 352:635-41.
9. Hart, H.L.A., and A. M. Honoré. 1985. Causation in the law. 2d ed. Oxford.
10. Hodges, J. L., Jr., and E. Lehmann. 1964. Basic concepts of probability and statistics. San Francisco: Holden-Day.
11. Hoeffding, W. 1963. Probability inequalities for sums of bounded random variables. Journal of the American Statistical Association 58:13-30.
12. Holland, P. 1988. Causal inference, path analysis, and recursive structural equations models. In Sociological methodology, edited by C. Clogg. Washington, DC: American Sociological Association.
13. Hughes, R. A. 1990. Guillain-Barré syndrome. London: Springer-Verlag.
14. Hughes, R. A., and J. H. Rees. 1997. Clinical and epidemiologic features of Guillain-Barré syndrome. Journal of Infectious Diseases 176 (suppl. 2): S92-S98.
15. Hurwitz, E. S., L. B. Schonberger, D. B. Nelson, and R. C. Holman. 1981. Guillain-Barré syndrome and the 1978-1979 influenza vaccine. New England Journal of Medicine 304:1557-61.
16. Johnson, M. T., C. E. Drew, and D. P. Miletich. 1998. Use of expert testimony, specialized decision makers, and case-management innovations in the national vaccine injury compensation program. Washington, DC: Federal Judicial Center.
17. Kaplan, J. E., P. Katona, E. S. Hurwitz, and L. B. Schonberger. 1982. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981: Lack of an association with influenza vaccination. Journal of the American Medical Association 248:698-700.
18. Kurland, L. T., W. C. Wiederholt, J. W. Kirkpatrick, H. G. Potter, and P. Armstrong. 1985. Swine influenza vaccine and Guillain-Barré syndrome. Epidemic or artifact? Archives of Neurology 42:1089-90.
19. Langmuir, A. D. 1979. Guillain-Barré syndrome: The swine influenza virus vaccine incident in the United States of America, 1976-77: Preliminary communication. Journal of the Royal Society of Medicine 72:660-69.
20. Langmuir, A. D., D. J. Bregman, L. T. Kurland, N. Nathanson, and M. Victor. 1984. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. American Journal of Epidemiology 119:841-79.
21. Lasky, T., G. J. Terracciano, L. Magder, C. L. Koski, M. Ballesteros, D. Nash, S. Clark, P. Haber, P. D. Stolley, L. B. Schonberger, and R. T. Chen. 1998. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New England Journal of Medicine 339:1797-1802.
22. Manski, C. F. 1995. Identification problems in the social sciences. Cambridge, MA: Harvard University Press.
23. Marks, J. S., and T. J. Halpin. 1980. Guillain-Barré syndrome in recipients of A/New Jersey influenza vaccine. Journal of the American Medical Association 243:2490-94.
24. Nachamkin, I., B. M. Allos, and T. Ho. 1998. Campylobacter species and Guillain-Barré syndrome. Clinical Microbiology Reviews 11:555-67.
25. Neustadt, R. E., and H. V. Fineberg. 1982. The epidemic that never was: Policy-making and the swine flu affair. New York: Random House.
26. Neyman, J. 1923. Sur les applications de la théorie des probabilités aux experiences agricoles: Essai des principes. Roczniki Nauk Rolniczki 10:1-51 (in Polish). English translation by Dabrowska, D., and T. Speed. 1990. Statistical Science 5:463-80.
27. Neyman, J. 1923. Sur les applications de la théorie des probabilités aux experiences agricoles: Essai des principes. Roczniki Nauk Rolniczki 10:1-51 (in Polish). English translation by Dabrowska, D., and T. Speed. 1990. Statistical Science 5:463-80.
28. Pearl, S. 1999. Probabilities of causation: Three counterfactual interpretations and their identification. Technical report. Department of Computer Science, University of California, Los Angeles.
29. Petitti, D. B. 1996. Review of "Reference guide on epidemiology." Jurimetrics 36:159-68.
30. Robins, J., and S. Greenland. 1989a. Estimability and estimation of excess and etiologic fractions. Statistics in Medicine 8:845-59.
31. _. 1989b. The probability of causation under a stochastic model for individual risk. Biometrics 45:1125-38.
32. Ropper, A. H., E.F.M. Wijdicks, and B. T. Truax. 1991. Guillain-Barré syndrome. Philadelphia: F. A. Davis.
33. Rubin, D. 1974. Estimating causal effects of treatments in randomized and nonrandomized studies. Journal of Educational Psychology 66:688-701.
34. Safranek, T. J., D. N. Lawrence, L. T. Kurland, D. H. Culver, W. C. Wiederholt, N. S. Hayner, M. T. Osterholm, P. O'Brien, J. M. Hughes, and the Expert Neurology Group. 1991. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: Results of a two-state study. American Journal of Epidemiology 133:940-51.
35. Schonberger, L. B., D. J. Bregman, J. Z. Sullivan-Bolyai, R. A. Keenlyside, D. W. Ziegler, H. F. Retailliau, D. L. Eddins, and J. A. Bryan. 1979. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology 110:105-23.
36. Silverstein, A. M. 1981. Pure politics and impure science: The swine flu affair. Baltimore, MD: Johns Hopkins University Press.